Literature DB >> 17942077

Isoform-specific translocation of PKC isoforms in NIH3T3 cells by TPA.

Julhash U Kazi1, Jae-Won Soh.   

Abstract

Protein kinase C (PKC), a multi-gene family of enzymes, plays key roles in the pathways of signal transduction, growth control and tumorigenesis. Variations in the intracellular localization of the individual isoforms are thought to be an important mechanism for the isoform-specific regulation of enzyme activity and substrate specificity. To provide a dynamic method of analyzing the localization of the specific isoforms of PKC in living cells, we generated fluorescent fusion proteins of the various PKC isoforms by using the green fluorescent protein (GFP) as a fluorescent marker at the carboxyl termini of these enzymes. The intracellular localization of the specific PKC isoforms was then examined by fluorescence microscopy after transient transfection of the respective PKC-GFP expression vector into NIH3T3 cells and subsequent TPA stimulation. We found that the specific isoforms of PKC display distinct localization patterns in untreated NIH3T3 cells. For example, PKCalpha is localized mainly in the cytoplasm while PKCepsilon is localized mainly in the Golgi apparatus. We also observed that PKCalpha, beta1, beta2, gamma, delta, epsilon, and eta translocate to the plasma membrane within 10 min of the start of TPA treatment, while the cellular localizations of PKCzeta and iota were not affected by TPA. Using a protein kinase inhibitor, we also showed that the kinase activity was not important for the translocation of PKC. These results suggest that specific PKC isoforms exert spatially distinct biological effects by virtue of their directed translocation to different intracellular sites.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17942077     DOI: 10.1016/j.bbrc.2007.09.123

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

Review 1.  Protein kinase C (PKC) as a drug target in chronic lymphocytic leukemia.

Authors:  Julhash U Kazi; Nuzhat N Kabir; Lars Rönnstrand
Journal:  Med Oncol       Date:  2013-10-31       Impact factor: 3.064

2.  Specific subcellular targeting of PKCalpha and PKCepsilon in normal and tumoral lactotroph cells by PMA-mitogenic stimulus.

Authors:  Juan Pablo Petiti; Silvina Gutiérrez; Jorge Humberto Mukdsi; Ana Lucía De Paul; Alicia Inés Torres
Journal:  J Mol Histol       Date:  2010-02-23       Impact factor: 2.611

Review 3.  Genetically encodable fluorescent biosensors for tracking signaling dynamics in living cells.

Authors:  Robert H Newman; Matthew D Fosbrink; Jin Zhang
Journal:  Chem Rev       Date:  2011-04-01       Impact factor: 60.622

Review 4.  Grb10 is a dual regulator of receptor tyrosine kinase signaling.

Authors:  Nuzhat N Kabir; Julhash U Kazi
Journal:  Mol Biol Rep       Date:  2014-01-14       Impact factor: 2.316

5.  Role of protein kinase C β₂ in relaxin-mediated inhibition of cardiac fibrosis.

Authors:  W Su; P Wang; H Chen; H Li
Journal:  J Endocrinol Invest       Date:  2014-04-11       Impact factor: 4.256

6.  Inhibition of protein kinase C delta attenuates blood-retinal barrier breakdown in diabetic retinopathy.

Authors:  Jeong-Hun Kim; Jin Hyoung Kim; Hyoung-Oh Jun; Young Suk Yu; Kyu-Won Kim
Journal:  Am J Pathol       Date:  2010-01-28       Impact factor: 4.307

7.  ARF1-regulated coatomer directs the steady-state localization of protein kinase C epsilon at the Golgi apparatus.

Authors:  Tabitha A Peterson; Mark Stamnes
Journal:  Biochim Biophys Acta       Date:  2012-11-27

Review 8.  Phosphorylation-Dependent Regulation of WNT/Beta-Catenin Signaling.

Authors:  Kinjal Shah; Julhash U Kazi
Journal:  Front Oncol       Date:  2022-03-14       Impact factor: 6.244

9.  PKC-β modulates Ca2+ mobilization through Stim1 phosphorylation.

Authors:  Hye-Jin Song; In-Sook Jeon; Seung Ryul Kim; Kwan Sik Park; Jae-Won Soh; Kwang Youl Lee; Jae-Cheon Shin; Hak-Kyo Lee; Joong-Kook Choi
Journal:  Genes Genomics       Date:  2022-03-07       Impact factor: 2.164

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.